[6] [7] Common adverse effects include nausea, vomiting, diarrhoea, constipation, abdominal pain, and decreased appetitemost of which are mild to moderate and tend to diminish over time
More data are required to determine which patients with OSA are most likely to benefit from tirzepatide
No, the elimination half-life remains constant at approximately seven days regardless of dose
Studies using a high-fat diet (HFD) induced obesity mice model characterized by decreased serum T levels, impaired sperm quality, and increased testis inflammation, showed that exenatide administration was able to reduce body weight and improve the quality of sperm without increasing serum T levels but lowering the expression of proinflammatory cytokines (25)
Despite producing nearly 10 percentage points more weight loss, Retatrutide causes less nausea, less vomiting, and similar rates of other gastrointestinal symptoms